These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 15746036

  • 1. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S.
    Clin Cancer Res; 2005 Feb 15; 11(4):1380-5. PubMed ID: 15746036
    [Abstract] [Full Text] [Related]

  • 2. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z, Li X, Hu J, Zhou W, Jiang Y, Li G, Lu D.
    Neurosci Res; 2006 Dec 15; 56(4):450-8. PubMed ID: 17049657
    [Abstract] [Full Text] [Related]

  • 3. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y, Tong D, Lou G, Zhang Y, Geng J.
    Pathobiology; 2008 Dec 15; 75(4):244-51. PubMed ID: 18580070
    [Abstract] [Full Text] [Related]

  • 4. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B.
    Clin Cancer Res; 2005 Mar 15; 11(6):2156-62. PubMed ID: 15788661
    [Abstract] [Full Text] [Related]

  • 5. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.
    Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139
    [Abstract] [Full Text] [Related]

  • 6. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 7. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
    Breast Cancer Res; 2008 Apr 01; 10(5):R82. PubMed ID: 18826564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 06; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM.
    Clin Cancer Res; 2003 Apr 06; 9(4):1441-5. PubMed ID: 12684417
    [Abstract] [Full Text] [Related]

  • 17. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
    Hui R, Macmillan RD, Kenny FS, Musgrove EA, Blamey RW, Nicholson RI, Robertson JF, Sutherland RL.
    Clin Cancer Res; 2000 Jul 06; 6(7):2777-87. PubMed ID: 10914724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N.
    Oncol Rep; 2004 Nov 06; 12(5):1087-92. PubMed ID: 15492797
    [Abstract] [Full Text] [Related]

  • 20. Hypermethylation in histologically distinct classes of breast cancer.
    Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, Herman JG, Gabrielson E.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.